At a Glance
- Tasks: Lead the clinical trial activation process and develop innovative study start-up strategies.
- Company: Join Merck Group, a leader in healthcare innovation.
- Benefits: Hybrid work model, competitive salary, and opportunities to shape patient therapies.
- Other info: Work in a dynamic environment with a focus on innovation and patient care.
- Why this job: Make a real difference in patients' lives through groundbreaking clinical research.
- Qualifications: Strong clinical research experience and excellent communication skills required.
The predicted salary is between 50000 - 65000 £ per year.
Merck Group is seeking a Study Start-Up Lead to join their Healthcare team. This role involves overseeing the end-to-end clinical trial activation process and developing strategies for study start-up. The position offers the opportunity to shape innovative therapies and support patients at every stage of life.
Candidates should have substantial clinical research experience, strong regulatory knowledge, and excellent communication skills. The role is hybrid, requiring a minimum of 3 days on-site in Feltham, UK.
Study Start-Up Lead: Feasibility & Global Site Activation employer: Merck Group
At Merck Group, we pride ourselves on being an excellent employer, offering a dynamic work environment that fosters innovation and inclusion. As a Rare Tumours Territory Lead in Scotland and Northern Ireland, you will have the opportunity to make a meaningful impact on patient care while benefiting from professional growth opportunities and a supportive team culture. Our commitment to employee development and collaboration ensures that you can thrive in your role and contribute to driving human progress in healthcare.
